glp-1 receptor agonists in pediatric and adolescent obesity diabetes: a systematic review of efficacy, metabolic effects, and safety Role of GLP-1 Receptor Agonists

Liver and diabetes

Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide

Physical activity represents a potent, evidence-based intervention for enhancing metabolic health through multiple mechanisms, including improved insulin sensitivity, glucose utilization, and cardiovascular function

It is used as an adjunctive therapy, along with diet and exercise, to help manage blood sugar levels and promote weight reduction in adults with T2DM [61]

[1] Healthcare providers may need to adjust the dosages of these concomitant medications to mitigate the risk of hypoglycemia

In a phase 1 double-blind randomized study, in which participants either received LY3298176 or a placebo, Coskun et al